See All Slides - tctmd.com

Slides

Presentation TCT 2012

Nanoparticle-Based Stents 1: Mitsui (Meril Life Sciences) Program Update

Presenter: Ricardo Costa

October 23, 2012

Presentation TCT 2012

Preclinical Review: Experimental Considerations and Challenges for TAVR Validation

Presenter: Stanton Rowe

October 23, 2012

Presentation TCT 2012

Hybrid Revascularization: The Vanderbilt Approach

Presenter: David Zhao

October 23, 2012

Presentation TCT 2012

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

Presenter: Szilard Voros

October 23, 2012

Presentation TCT 2012

BioMime (Meril Life Sciences) Program Update

Presenter: Ashok Seth

October 23, 2012

Presentation TCT 2012

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

Presenter: Jan-Henk Dambrink

October 23, 2012

Presentation TCT 2012

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Presenter: Joerg Kempfert

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

Presenter: Jeffrey Kuvin

October 23, 2012

Presentation TCT 2012

From Access to the Coronaries: Strategies for Success and Troubleshooting

Presenter: Douglas Fraser

October 23, 2012

Presentation TCT 2012

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Presenter: Pedro Moreno

October 23, 2012

Advertisement

Slides

Nanoparticle-Based Stents 1: Mitsui (Meril Life Sciences) Program Update

Preclinical Review: Experimental Considerations and Challenges for TAVR Validation

Hybrid Revascularization: The Vanderbilt Approach

CTA Imaging and Prognosis: From Calcium Scoring to Coronary Anatomy

BioMime (Meril Life Sciences) Program Update

TCT-58. Effects of Mechanical Thrombectomy and Intracoronary Abciximab on Coronary Flow and Infarct Size During Primary PCI: Analysis from the INFUSE-AMI Trial

TCT-101. 12-month Results of a 2nd Generation Transapical Aortic Bioprosthesis for the Treatment of Patients with Severe Aortic Stenosis

Late Breaking Clinical Trials: Venous Thromboembolic Disease EINSTEIN-PE (Rivaroxaban)

From Access to the Coronaries: Strategies for Success and Troubleshooting

Do Statins and Other Therapies Alter Vulnerable Plaque Characteristics? Insights from Imaging

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content